CILF:在Saccharomyces cerevisiae中基于CRISPR/Cas9的大型DNA片段的整合
Shijie Xu1, Jie Meng1,2, Qi Zhang1
1Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Biotechnology and bioengineering
|August 18, 2024
概括
一种新的基于CRISPR/Cas9的大型DNA片段集成 (CILF) 方法有效地集成酵母细胞工厂中的大型DNA片段. 这一突破增强了合成生物学和代谢工程应用.
科学领域:
- 合成生物学 合成生物学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 基因组集成对于构建工程细胞工厂至关重要.
- 目前的方法难以有效地整合大型DNA片段.
- 提高DNA整合效率是推动合成生物学发展的关键.
研究的目的:
- 在Saccharomyces cerevisiae中开发一种高效的大型DNA片段集成的新方法.
- 提高酵母作为合成生物学应用的细胞工厂的能力.
主要方法:
- 开发了基于CRISPR/Cas9的大型DNA片段集成 (CILF) 方法.
- 一种融合蛋白 (Cas9-Brex27-FadR) 用于向的DNA传递和同源重组 (HR) 增强.
- 使用Rad51招聘来提高人力资源的效率.
主要成果:
- 对于10kB的DNA片段,CILF实现了98%的整合效率.
- 几乎80%的整合效率被观察到40kB的DNA片段在一个单一的网站.
- 该方法使用了在捐赠体等离子体上特定的同质臂和FadR结合位.
结论:
- 这种CILF技术显著改善了Saccharomyces cerevisiae中大DNA片段的整合.
- 这种方法扩大了酵母的合成生物学工具箱.
- CILF具有在合成生物学和代谢工程领域取得进展的潜力.
相关概念视频
CRISPR
50.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.0K
Homologous Recombination
50.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.3K


